VAERS reports by lot

GSK Varicella/Shingles lot G72Z4: VAERS reports

25 VAERS reports list lot G72Z4 as a GSK Varicella/Shingles vaccine, received between 2020-02-12 and 2021-03-27. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
25
Reports
0%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1823%
General / Systemic (non-local)1722%
Dermatological (non-injection-site)1215%
Musculoskeletal810%
Allergic / Anaphylactic56%
Gastrointestinal56%
Cardiac / Cardiovascular45%
Respiratory45%
Neurological34%
Autoimmune / Immune-mediated11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania3
Idaho2
New Hampshire2
Wisconsin2
Colorado1
Connecticut1
Alaska1
New Jersey1
California1
Maine1
Oregon1
Illinois1

Reports by month received

2020-028
2020-035
2020-041
2020-061
2020-071
2020-082
2020-091
2020-102
2020-121
2021-033

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.